, Tracking Stock Market Picks
Enter Symbol:
Amylin Pharmaceuticals, Inc. (AMLN) [hlAlert]

up 45.73 %

Amylin Pharmaceuticals, Inc. (AMLN) rated Buy by Merriman

Posted on: Thursday,  Mar 11, 2010  8:25 AM ET by Merriman

Merriman rated Buy Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) on 03/11/2010, when the stock price was $21.23. Since
then, Amylin Pharmaceuticals, Inc. has gained 45.74% as of 08/06/2012's recent price of $30.94.
If you would have followed this Merriman's recommendation on AMLN, you would have gained 45.73% of your investment in 879 days.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over one thousand five hundred employees nationwide.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/11/2010 8:25 AM Buy
as of 12/31/2010
1 Week down  -0.59 %
1 Month up  17.23 %
3 Months down  -27.91 %
1 YTD down  -29.20 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy